NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Psoriasis Longitudinal Assessment and Registry

Active Not RecruitingN/A

Sponsor: Janssen Scientific Affairs, LLC

Conditions: Psoriasis

Countries: United States, Argentina, Australia, Austria, Belgium, Canada, Chile, Colombia

The purpose of this study is to further evaluate the safety of infliximab, ustekinumab, and guselkumab in patients with plaque and other forms of psoriasis. The study also includes patients receiving other therapies, such as non-biologic and other biologic agents. The registry also evaluates patient and disease characteristics, including patient-reported assessment of psoriatic arthritis (PsA); and clinical and quality of life outcomes.

Eligibility overview

Sex: ALL

Age: 18 Years to 99 Years

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Have a diagnosis of psoriasis
* Incident or prevalent users of Tremfya or an IL-17 inhibitor (eg, secukinumab, ixekizumab, brodalumab, bimekizumab) at the time of their enrollment. Incident users are defined as those participants starting treatment within 30 days before or after the enrollment visit and prevalent users are defined as those who are on treatment greater than 30 days prior to the enrollment visit
* Ability to understand and sign an informed consent form
* Are willing to participate in regular follow-up visits

Exclusion Criteria:

* Refuse to consent or are unwilling to respond to requests for long term information within the required time frame
* Are participating or have already planned to participate in a clinical trial with non-marketed investigational agents or are participating in a Janssen-sponsored clinical trial with marketed agents

Locations (320)

Birmingham, Alabama, United States
Florence, Alabama, United States
Huntsville, Alabama, United States
Phoenix, Arizona, United States
Scottsdale, Arizona, United States
Tucson, Arizona, United States
Rogers, Arkansas, United States
Bakersfield, California, United States
Clovis, California, United States
Fountain Valley, California, United States
Fresno, California, United States
Loma Linda, California, United States
Los Angeles, California, United States
Mountain View, California, United States
Oxnard, California, United States
Redding, California, United States
Rolling Hills Estates, California, United States
San Diego, California, United States
San Ramon, California, United States
Santa Monica, California, United States
Sherman Oaks, California, United States
Upland, California, United States
Vallejo, California, United States
Colorado Springs, Colorado, United States
Englewood, Colorado, United States
Bridgeport, Connecticut, United States
Farmington, Connecticut, United States
Newark, Delaware, United States
Wilmington, Delaware, United States
Washington D.C., District of Columbia, United States
+ 290 more on CT.gov